Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for Lung Nodules in High-Risk Patients
NCT00321893Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in lung cancer, sponsored by National Cancer Institute. Started Jan 2006; status: completed.
02
Drugs
budesonide
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00321893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321893.